Tag Archives: public policy

Drug Reimbursement and the "New Medicaid"

By Guest Blogger | Published: August 9, 2012
by Tom Norton A lot has been written about the “state option” created by the Supreme Court ruling on HCR, and what it means to American medicine. Sorting out an opinion will, to a degree, depend on whom you read and what you believe. But regardless of where you come out on this issue, there is little [...]
Posted in Guest Blog, Legal, Market Access, R&D, Regulatory, healthcare | Also tagged , , , , , , , | 1 Comment

Naughty Localities Need to Obey NICE, or Else!

By Ben Comer | Published: July 18, 2012
Like governors in the US vowing to block Medicaid expansion in their home states, local primary care trusts (PCTs) in the UK don’t always follow national guidelines on drug access due to budgetary concerns. But that may change in 2013; according to comments made by Minister David Willetts last month, NHS could face monetary penalties [...]
Posted in Agency Insight, Global, Legal, Market Access, Regulatory, Strategy, healthcare, pricing | Also tagged , , , , , , , | Leave a comment

Clayton Christensen on the Future of Pharma

By Ben Comer | Published: May 11, 2012
A keynote speaker at the 9thAnnual SaS Health Care & Life Sciences Executive Conference on May 10, ‘disruptive’ author of The Innovator’s Dilemma and Harvard business professor Clayton Christensen sat down with PharmExec to discuss the future of the pharmaceutical industry, and what Mitt Romney could bring to the White House.
Posted in Biotech, Events, FDA, IP, People, R&D, Regulatory, Safety, Technology, Uncategorized, healthcare, leadership | Also tagged , , , , , , , , , , , | 1 Comment